BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29224006)

  • 1. Epigenetic Regulation of the Promotor Region of Vascular Endothelial Growth Factor-A and Nerve Growth Factor in Opioid-Maintained Patients.
    Groh A; Jahn K; Burkert A; Neyazi A; Schares L; Janke E; Rehme M; Schuster R; Hillemacher T; Bleich S; Frieling H; Heberlein A
    Eur Addict Res; 2017; 23(5):249-259. PubMed ID: 29224006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment.
    Schuster R; Kleimann A; Rehme MK; Taschner L; Glahn A; Groh A; Frieling H; Lichtinghagen R; Hillemacher T; Bleich S; Heberlein A
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):33-40. PubMed ID: 26801497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of nerve growth factor and vascular endothelial growth factor A with psychometric measurements of opiate dependence: results of a pilot study in patients participating in a structured diamorphine maintenance program.
    Heberlein A; Dürsteler-MacFarland KM; Frieling H; Gröschl M; Lenz B; Bönsch D; Kornhuber J; Wiesbeck GA; Bleich S; Hillemacher T
    Eur Addict Res; 2012; 18(5):213-9. PubMed ID: 22517242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Effects of Intravenous Diacetylmorphine on the Methylation of POMC and NR3C1.
    Groh A; Rhein M; Buchholz V; Burkert A; Huber CG; Lang UE; Borgwardt SJ; Heberlein A; Muschler MAN; Hillemacher T; Bleich S; Frieling H; Walter M
    Neuropsychobiology; 2017; 75(4):193-199. PubMed ID: 29510398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
    Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
    Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical update: codeine maintenance in opioid dependence.
    Hall WD; Mattick RP
    Lancet; 2007 Aug; 370(9587):550-2. PubMed ID: 17707737
    [No Abstract]   [Full Text] [Related]  

  • 8. Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.
    Haasen C; Verthein U; Eiroa-Orosa FJ; Schäfer I; Reimer J
    Eur Addict Res; 2010; 16(3):124-30. PubMed ID: 20424456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.
    Kim J; Hwang J; Jeong H; Song HJ; Shin J; Hur G; Park YW; Lee SH; Kim J
    Epigenetics; 2012 Feb; 7(2):191-200. PubMed ID: 22395469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment.
    Gutwinski S; Schoofs N; Stuke H; Riemer TG; Wiers CE; Bermpohl F
    Harm Reduct J; 2016 Feb; 13():7. PubMed ID: 26879120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levomethadone Therapeutic Drug Monitoring to Aid Opioid Withdrawal Therapy: A Short Communication.
    Pfeifer P; Hildebrand K; Angelov A; Havemann-Reinecke U; Böttcher M; Hiemke C; Prentice T; Roll SC
    Ther Drug Monit; 2023 Dec; 45(6):772-776. PubMed ID: 37651587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic down regulation of nerve growth factor during alcohol withdrawal.
    Heberlein A; Muschler M; Frieling H; Behr M; Eberlein C; Wilhelm J; Gröschl M; Kornhuber J; Bleich S; Hillemacher T
    Addict Biol; 2013 May; 18(3):508-10. PubMed ID: 21392176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.
    Lee SY; Chen SL; Chang YH; Chu CH; Chen SH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv008. PubMed ID: 25716777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
    Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
    Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone induces hypermethylation of human DNA.
    Knothe C; Doehring A; Ultsch A; Lötsch J
    Epigenomics; 2016 Feb; 8(2):167-79. PubMed ID: 26340303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
    Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heroin or conventional opioid maintenance? The patients' perspective.
    Bald LK; Bermpohl F; Heinz A; Gallinat J; Gutwinski S
    J Addict Med; 2013; 7(6):401-4. PubMed ID: 24145159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.